Human neutrophil elastase and collagenase sequestration with phosphorylated cotton wound dressings

Journal of Biomedical Materials Research - Part A

Volumn 83, Issue 2, 2007, Pages 446-454

  Edwards, J Vincent ^a   Howley, Phyllis S ^a  

^a SOUTHERN REGIONAL RESEARCH CENTER   (United States)

Author keywords

Chronic wound dressing; Collagenase; Elastase lowering; Human neutrophil elastase; Mechanism based wound dressing; Phosphorylated cellulose; Protease sequestration

Indexed keywords

COTTON; PH EFFECTS; PHOSPHORYLATION; SALTS;

CHRONIC WOUND DRESSING; COLLAGENASE; ELASTASE LOWERING; HUMAN NEUTROPHIL ELASTASE; MECHANISM-BASED WOUND DRESSING; PHOSPHORYLATED CELLULOSE; PROTEASE SEQUESTRATION;

ENZYMES;

BOVINE SERUM ALBUMIN; CELLULOSE; COLLAGENASE; ELASTASE; HEXAMETAPHOSPHATE SODIUM; LEUKOCYTE ELASTASE; MATRIX METALLOPROTEINASE; PROTEINASE;

ARTICLE; CHEMICAL STRUCTURE; DOSE RESPONSE; ENZYME ASSAY; INFRARED SPECTROSCOPY; PH; PHOSPHORYLATION; PROTEIN DEGRADATION; WOUND DRESSING; WOUND FLUID; WOUND HEALING;

ANIMALS; CATTLE; CELLULOSE; COLLAGENASES; GOSSYPIUM; HUMANS; LEUKOCYTE ELASTASE; OCCLUSIVE DRESSINGS; PHOSPHATES; PHOSPHORYLATION; SERUM ALBUMIN, BOVINE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SUBSTRATE SPECIFICITY; SWINE;

EID: 35048879342     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31171     Document Type: Article

References (39)

1. Edwards JV. Future structure and properties of mechanism-based wound dressings. In: Edwards JV, Buschle-Diller G, Goheen SC, editors. Modified Fibers with Medical and Specialty Applications. Netherlands: Springer; 2006. pp 11-33.
2. Schultz GS, Sibbald RG, Falanga V, Ayello EA, Dowsett C, Harding K, Romanelli M, Stacey M.C, Teot L, Vanscheidt W. Wound bed preparation: A systematic approach to wound management. Wound Repair Regen 2003;11 (Suppl 1):S1-S28.
3. Nwomeh BC, Yager DR, Cohen IK. Physiology of the chronic wound. Clin Plast Surg 1998;25:341-356.
4. Schultz GS, Ladwig G, Wysocki A. Extracellular matrix: Review of its roles in acute and chronic wounds. World Wide Wounds (online) August 2005; 10-14. Available at http://www.worldwidewounds.com/2005/august/Schultz/Extrace- Matric-Acute-Chronic-Wounds.html.
5. Clark RAF. Wound repair: Overview and general considerations. In: Richard AFC, editor. The Molecular and Cellular Biology of Wound Repair. New York: Plenum; 1996. pp 3-35.
6. Morgan D. Wounds - What should a dressing formulary include? Hosp Pharm 2002;9:261-266.
7. Diegelmann RF. Excessive neutrophils characterize chronic pressure ulcers. Wound Repair Regen 2003;11:490-495.
8. Yager DR, Nwomeh BC. The proteolytic environment of chronic wounds. Wound Repair Regen 1999;7:433-441.
9. James TJ, Hughes MA, Cherry GW, Taylor RP. Evidence of oxidative stress in chronic venous ulcers. Wound Repair Regen 2003;11:172-176.
10. Ekerot L, Ohlsson K. Interactions of granulocyte proteases with inhibitors in rheumatoid arthritis. Adv Exp Med Biol 1984;167:335-344.
11. Shapiro SD. Proteinases in chronic obstructive pulmonary disease. Bioehem Soc Trans 2002;30:98-102.
12. Jaffray C, Yang J, Carter G, Mendez C, Norman J. Pancreatic elastase activates pulmonary nuclear factor kappa B and inhibitory κ B, mimicking pancreatitis-associated adult respiratory distress syndrome. Surgery 2000;128:225-231.
13. Trengrove NJ, Stacey MC, Macauley S, Bennett N, Gibson F, Burslem F, Murphy G, Schultz G. Analysis of the acute and chronic wound environments: The role of proteasese and their inhibitors. Wound Repair Regen 1999;7:442-452.
14. Bullen EC, Longaker MT, Updike DL, Benton R, Ladin D, Hou Z, Howard EW. Tissue inhibitor of metalloproteinase-1 is decreased and activated gelatinases are increased in chronic wounds. J Invest Dermatol 1995;104:236-240.
15. Yager DR, Zhang L, Liang H, Diegelmann RF, Cohen IK. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Dermatol 1996;107:743-748.
16. Grinell F, Zhu M. Identification of neutrophil elastase as the proteinase in burn wound fluid responsible for degradation of fibronectin. J Invest Dermatol 1994;103:155-161.
17. Yager DR, Chen SM, Ward SI, Olutoye OO, Diegelmann RF, Cohen IK. Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and dimished levels of proteinase inhibitors. Wound Repair Regen 1997;5:23-32.
18. Falanga V. Occlusive wound dressings. Why, when, which? Arch Dermatol 1988;124:872-877.
19. Wiseman DM, Rovee DT, Alvarez OM. Wound dressings: Design and use. In: Cohen IK, Diegelmann RF, Lindblad WJ, editors. Wound Healing: Biochemical and Clinical Aspects. Philadelphia: Saunders; 1992. pp 562-580.
20. Cullen B, Smith R, McCulloch E, Silcock D, Morrison L. Mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcers. Wound Repair Regen 2002;10:16-25.
21. Wright JB, Lam K, Buret AG, Olson ME, Burrell RE. Early healing events in a procine model of contaminated wounds: Effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing. Wound Repair Regen 2002;10:141-151.
22. Meyer-Ingold W, Eichner W, Ettner N, Schink M. Wound coverings for removal of interfering factors from wound fluid. US Patent6,156,334, 2000.
23. Edwards JV, Yager DR, Cohen IK, Diegelmann RF, Montante S, Bertoniere N, Bopp AF. Modified cotton gauze dressings that selectively absorb neutrophil elastase activity in solution. Wound Repair Regen 2001;9:50-58.
24. Edwards JV, Batiste SL, Gibbins EM, Goheen SC. Synthesis and activity of NH2- and COOH-terminal elastase recognition sequences on cotton. J Pept Res 1999;54:546-543.
25. Edwards JV, Eggleston G, Yager DR, Cohen IK, Diegelmann RF, Bopp AF. Design, preparation and assessment of citrate-linked monosaccharide cellulose conjugates with elastase-lowering activity. Carbohydr Polym 2002;50:305-314.
26. Vachon, DJ, Yager DR. Novel sulfonated hyrogel composite with the abililty to inhibit proteases and bacterial growth. J Biomed Mater Res A 2006;76:35-43.
27. Trengove NJ, Langton SR, Stacey MC. Biochemical analysis of wound fluid from nonhealing and healing chronic leg ulcers. Wound Repair Regen 1996;4:234-239.
28. Silverstein RM, Bassler GC, Morrill TC. Spectrometric Identification of Organic Compounds, 5th ed. New York: Wiley; 1991. pp 162-164.
29. Watorek W, Farley D, Salvesen G, Travis J. Neutrophil elastase and cathepsin G: Structure, function, and biological control. Adv Exp Med Biol 1988;240:23-31.
30. Meddahi A, Hassan L, Caruelle J-P, Barritault D, Hornebeck W. FGF protections and inhibition of human neutrophil elastase by carboxymethyl benzylamide sulfonate dextran derivatives. Int J Biol Macromol 1996;18:141-145.
31. Birkedahl-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA. Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 1993;4:197-250.
32. Jung W, Winter H. Considerations for the use of clostridial collagenase in clinical practice. Clin Drug Invest 1998;15:245-252.
33. Boxer AM, Gottesman N, Bernstein H, Mandl I. Debridement of dermal ulcers and decubiti with collagenase. Geriatrics 1969;24:75-86.
34. Bode W, Reinemer P, Huber R, Kleine T, Schnierer S, Tschesche H. The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity. EMBO J 1994;13:1263-1269.
35. Teronen O, Heikkila P, Konttinen YT, Laitinen M, Salo T, Hanemaaijer R, Teronen A, Maisi P, Sorsa T. MMP inhibition and downregulation by bisphosphonates. Ann NY Acad Sci 1999;878:453-465.
36. Gavuzzo E, Pochetti G, Campestre C, Agamennone M, Tortorella P, Consalvi V, Gallina C, Hiller O, Tschesche H, Tucker PA, Mazza F. Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates. J Med Chem 2006;49:923-931.
37. Natarajan S, van Wullen L, Klein W, Jansen M. Synthesis of a single four-ring (S4R) molecular zinc phosphate and its assembly to an extended polymeric structure: A single-crystal and in-situ MAS NMR investigation. Inorg Chem 2003;42:6265-6273.
38. Kleifeld O, Van den Steen PI, Frenkel A, Cheng F, Jiang HL, Opdenakker G, Sagi I. Structural characterization of the catalytic active site in the latent and active natural gelatinase B from Human Neutrophils. J Biol Chem 2000;275:34335-34343.
39. James TJ, Hughes MA, Cherry GW, Taylor RP. Simple biochemical markers to assess chronic wounds. Wound Repair Regen 2000;8:264-269.